Published in J Neurol Neurosurg Psychiatry on May 01, 1991
Anti-acetylcholine receptor antibody measurement in myasthenia gravis. J Neurol Neurosurg Psychiatry (1993) 0.75
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology (1976) 4.93
Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet (1986) 4.07
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
Remission of myasthenia gravis following plasma-exchange. Lancet (1976) 2.25
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Myasthenia gravis: evaluation of treatment in 1,355 patients. Neurology (1966) 1.98
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol (1982) 1.78
Myasthenia gravis and myasthenic syndromes. Ann Neurol (1984) 1.77
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients. J Neurol Sci (1983) 1.69
The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci (1981) 1.27
Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations. Ann Neurol (1981) 1.19
Acetylcholine receptor antibody in myasthenia gravis: purification and characterization. Scand J Immunol (1978) 1.19
Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients. Isr J Med Sci (1978) 1.09
Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.01
Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravis. Ann N Y Acad Sci (1981) 0.93
The human acetylcholine receptor antibody: studies of kinetic and biochemical properties and the reaction with anti-idiotypic antibodies. Ann N Y Acad Sci (1981) 0.89
Prevalence of multiple sclerosis in north-east Scotland. Br Med J (1978) 3.25
A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry (1980) 2.71
Phosphatidate accumulation in hormone-treated hepatocytes via a phospholipase D mechanism. J Biol Chem (1987) 2.40
Hyperextension injuries to the cervical cord in the elderly. BMJ (1989) 1.61
Sino-atrial arrest due to temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1987) 1.60
Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br J Pharmacol (1976) 1.51
Phosphatidate-dependent protein phosphorylation. Proc Natl Acad Sci U S A (1991) 1.39
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology (1989) 1.29
Ca2+-mobilizing hormones elicit phosphatidylethanol accumulation via phospholipase D activation. FEBS Lett (1987) 1.25
Benefit from adrenocorticotrophin in myasthenia gravis. J Neurol Neurosurg Psychiatry (1974) 1.17
The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. J Physiol (1975) 1.13
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer (2000) 1.09
The hormone-sensitive hepatic Na+-pump. Evidence for regulation by diacylglycerol and tumor promoters. J Biol Chem (1986) 1.09
Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Clin Exp Immunol (1992) 1.08
Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.07
TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer (1999) 1.03
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet (1993) 0.98
Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology (1993) 0.96
Treatment of polyneuropathy with azathioprine. Lancet (1970) 0.95
Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis (1996) 0.95
Icarus's syndrome: new hazards in flight. Br Med J (1977) 0.95
The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease. Atherosclerosis (2000) 0.94
IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol (1994) 0.92
Evidence for circulating complexes containing IgE in patients with atopic dermatitis. Int Arch Allergy Appl Immunol (1985) 0.92
Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol Scand (1979) 0.92
A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Br J Clin Pract (1972) 0.91
Acute polyneuropathy complicating chronic renal failure. Nephron (1971) 0.89
Clinical spectrum of neuroleptic malignant syndrome. Lancet (1988) 0.89
Proceedings: The actions of halothane and pentobarbitone on the sensitivity of neurones in the guinea-pig prepiriform cortex to iontophoretically applied L-glutamate. J Physiol (1974) 0.89
Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry (1995) 0.88
General anaesthetics and the acetylcholine-sensitivity of cortical neurons. Br J Pharmacol (1976) 0.88
Suppression of "rubral" tremor with levodopa. Br Med J (1980) 0.84
Agonist-induced down-regulation of the angiotensin II receptor in primary cultures of rat hepatocytes. J Biol Chem (1988) 0.84
Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer. Int J Cancer (1998) 0.83
Investigation of IgG4 levels in atopic patients using a competitive inhibition assay employing biotinylated IgG4 myeloma and avidin peroxidase. J Immunol Methods (1986) 0.82
Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin Exp Rheumatol (1994) 0.81
Actinomycin-D treatment in a case of acute intermittent porphyria. Lancet (1970) 0.81
Megaloblastic anaemia due to trimethoprim-sulphamethoxazole therapy in uraemia. Postgrad Med J (1973) 0.79
Cortical blindness in a 35-year-old man. Postgrad Med J (1996) 0.79
Serum soluble CD23 in patients with hypogammaglobulinaemia. Clin Exp Immunol (1994) 0.78
An early elevation of diacylglycerol and phosphatidate in regenerating liver. Biochem Biophys Res Commun (1989) 0.78
Specific immunoglobulin E to peanut, hazelnut and brazil nut in 731 patients: similar patterns found at all ages. Clin Exp Allergy (1999) 0.78
Idoxuridine and motor neurone disease. Br Med J (1970) 0.78
Abetalipoproteinaemia. A case report with pathological studies. Postgrad Med J (1976) 0.78
Eosinophilic leukaemia terminating with an encephalopathy. Postgrad Med J (1974) 0.77
Immunodetection and characterisation of soluble CD105-TGFbeta complexes. J Immunol Methods (1998) 0.77
Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA. J Immunol Methods (1994) 0.77
Adult-onset hereditary ataxia in Scotland. Arch Neurol (1977) 0.77
Congenital non-progressive peripheral neuropathy with arthrogryposis multiplex. J Neurol Neurosurg Psychiatry (1974) 0.77
Silent nocardia cerebral abscesses in treated dermatomyositis. Postgrad Med J (1990) 0.76
Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc (1974) 0.76
Cellular and humoral immunity in patients with insulin-dependent diabetes. Lancet (1993) 0.75
Increased risk of multiple sclerosis among nurses and doctors. J Neurol Neurosurg Psychiatry (1991) 0.75
Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry (1994) 0.75
Delayed somatosensory evoked potentials in pernicious anaemia with intact peripheral nerves. J Neurol Neurosurg Psychiatry (1988) 0.75
Formed visual hallucinations with pituitary adenomas. Br Med J (Clin Res Ed) (1984) 0.75
Peanut allergy. Lancet (1998) 0.75
Amyloidosis complicated by intractable postural hypotension. Postgrad Med J (1973) 0.75
Prevalence of multiple sclerosis in north-east Scotland. Br Med J (1978) 0.75
Serum measurements of soluble CD23 in HIV infection. Immunology (1993) 0.75
Macs with multiple sclerosis. J Neurol Neurosurg Psychiatry (1999) 0.75
Interactions of L-dopa and amantadine in patients with Parkinsonism. J Neurol Neurosurg Psychiatry (1973) 0.75
Internuclear ophthalmoplegia and Horner's syndrome due to presumed giant cell arteritis. J R Soc Med (1993) 0.75
Letter: Effect of levodopa on Parkinsonian tremor. Br Med J (1976) 0.75
Letter: Methysergide ineffective in spasticity. Br Med J (1976) 0.75
Depth sense aesthesiometry: an advance in the clinical assessment of sensation in the hands. J Neurol Neurosurg Psychiatry (1981) 0.75
A novel mutation of SOD-1 (Gly 108 Val) in familial amyotrophic lateral sclerosis. Eur J Neurol (1997) 0.75
Parkinsonism and Huntington's chorea. Lancet (1971) 0.75
Increased incidence of antibody in pre-malignant occupational bladder cancer. Oncology (1982) 0.75
The management of acute poisoning in a provincial teaching hospital. Clin Toxicol (1971) 0.75
Magnetic resonance imaging with gadolinium-DTPA enhancement in the differentiation of benign from neoplastic cord cavitation. Clin Radiol (1990) 0.75
Letter: Transient oliguria due to peritoneal dialysis. Lancet (1974) 0.75
Sensory disturbances. Br Med J (Clin Res Ed) (1984) 0.75
Neurological picture. Aberrant regeneration of the third cranial nerve. J Neurol Neurosurg Psychiatry (1996) 0.75
Neurological complication of Mycoplasma pneumoniae infection. Respir Med (1989) 0.75
Neuroleptic malignant syndrome. Lancet (1989) 0.75
Letter: Retinal spectroscopy. Lancet (1975) 0.75
A critical appraisal of in-patient neurological services in a subregional centre. Br J Clin Pract (1992) 0.75
Myopathy and primary hyperaldosteronism. Neurology (1981) 0.75
Paroxysmal presentation of motor neurons disease. J Neurol Neurosurg Psychiatry (1987) 0.75
Motor vehicle component failures in road accidents. J Forensic Sci Soc (1969) 0.75
Serum sCD23 in patients with lepromatous and tuberculoid leprosy. Scand J Infect Dis (1998) 0.75
Letter: Thymoxamine ineffective against spasticity. Lancet (1973) 0.75